Skip to main content

Table 2 Health economic characteristics of the included HEEs (n =29)

From: Landscape and challenges in economic evaluations of artificial intelligence in healthcare: a systematic review of methodology

Author

Settings

Perspective

HEE type

DAM type or ACL

Primary outcome

ICER

Cost- effective alternative

Delgadillo et al.

Psychological therapy services

Health service

CEA

ACL

PHQ-9 measure

CT

Intervention

Fuller et al.

Primary care

Payer

CUA

Markov

QALY

$258,721.81/QALY

Intervention

Rossi et al.

CT

Payer

CUA

Markov

QALY

−$27,580/QALY

CT

Rossi et al.

CT

Payer

CEA

Markov

Tooth retention time

−€15.01/year

CT

Rossi et al.

CT

Payer

CUA

Markov

QALY

R-$91,760/QALY

CT

Hill et al.

Primary care

National health service

CUA

Decision tree and Markov

QALY

Systematic: £4,847/QALY

Opportunistic: £5,544/QALY

Intervention

Huang et al.

Health service stations

Health system and societal

CUA

Decision tree and Markov

QALY

Health system: $1,107.63/QALY

Societal: $1,0347.12/QALY

Intervention

Mervin et al.

Long-term care facilities

Healthcare

CEA

ACL

CMAI-SF

PARO: $13.01/CMAI-SF

Plush toy: $12.85/CMAI-SF

CT

Morrison et al.

CT

Healthcare

CEA

Decision tree

QALY

CT

CT

Nsengiyumva et al.

Health centre

Healthcare

CEA

Decision tree

DALY

CT

CT

Padula et al.

Hospital

Societal and healthcare

CUA

Markov

QALY

Healthcare: $2,142/QALY

Societal: $2,000/QALY

Intervention

Schwendicke et al.

Private dental practice

Healthcare

CEA

ACL

Tooth retention time

− €8.9/year

Control

Schwendicke et al.

CT

Public-private-payer healthcare

CEA

Markov

Tooth retention time

− €13.9 /year

Intervention

Tseng et al.

CT

Healthcare

CUA

Decision tree and Markov

QALY

$43,351/QALY

Intervention

Wolf et al.

CT

Family

CEA

Decision tree

True positive proportion

T1DM: $31/TPP

T2DM: $95/TPP

Intervention

Turino et al.

Hospital sleep unit

CT

CEA

ACL

Hours/day of CPAP use

CT

Intervention

Mallow et al.

Orthopaedic pain management

Payer and self-insured payer

CUA

Markov

QALY

CT

Intervention

Barkun et al.

Health care

Payer’s perspective

CUA

Markov

QALY and LY

CT

Intervention

Chawla et al.

Primary care

Health care payer

CUA

Markov

QALY

CT

Intervention

Hassan et al.

Primary screening

National health service

CUA

Markov

QALY

CT

Intervention

Hill et al.

Primary care

National health service

CUA

Decision tree and Markov

QALY

£3,994/QALY

Intervention

Lin et al.

Community health service center

Societal

CEA and CUA

Markov

Years without blindness per 100,000 people with DM, and QALY

ICER: $2553.39/year

ICUR: $15,216.96/ QALY

Control

Mital et al.

CT

Health care system

CUA

Decision tree and microsimulation

QALY

$23,755/QALY

Intervention

Pickhardt et al.

CT

CT

CUA

Markov

QALY

CT

Intervention

Shen et al.

Primary screening

Health care provider

CUA

Markov

QALY

$622–24,482/QALY

Intervention

Skarping et al.

CT

Health care

CUA

Decision tree

QALY

CT

Intervention

Srisubat et al.

CT

Health care provider and societal

CUA

Decision tree and Markov

QALY

Provider: $512,955/QALY

Societal: CT

CT

Yonazu et al.

CT

Medical payer

CUA

Decision tree and Markov

QALY

$11,0937QALY

Intervention

Ziegelmayer et al.

CT

Health care

CUA

Markov

QALY

CT

Intervention

  1. Key: HEE Health economic evaluation, PHQ-9 Patient health questionnaire, CT Cannot tell, CEA Cost-effectiveness analysis, CUA Cost-utility analysis, QALY Quality-adjusted life years, NHS National health service, DALY Disability-adjusted life year, TTP True positive proportion, ACL Alongside clinical trial, T1DM Type-1 diabetes mellitus, T2DM Type-2 diabetes mellitus, PHQ Patient health questionnaire, CPAP Continuous positive airway pressure, CMAI-SF Cohen–Mansfield Agitation Inventory-Short Form, DAM Decision-analytic model, ICER Incremental cost-effectiveness ratio, TPP True positive proportion, DM Diabetes mellitus, ANN Artificial Neural Network